title: [Efficacy and toxicity of a taxotere/cisplatin combination in first line chemotherapy in patients with disseminated ovarian cancer].
authors.forename: V A
authors.initials: VA
authors.lastname: Gorbunova
authors.forename: S V
authors.initials: SV
authors.lastname: Khokhlova
authors.forename: N S
authors.initials: NS
authors.lastname: Besova
authors.forename: N F
authors.initials: NF
authors.lastname: Orel
authors.forename: V V
authors.initials: VV
authors.lastname: Kuznetsov
authors.forename: A G
authors.initials: AG
authors.lastname: Bliumenberg
authors.forename: N B
authors.initials: NB
authors.lastname: Smirnova
authors.forename: M A
authors.initials: MA
authors.lastname: Chekalova
authors.forename: M E
authors.initials: ME
authors.lastname: Sinitsyna
authors.forename: B K
authors.initials: BK
authors.lastname: Poddubnyĭ
mesh_terms: D000328:Adult; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use*; D002945:Cisplatin / Q000008:administration & dosage*; D000077143:Docetaxel; D005260:Female; D006801:Humans; D008875:Middle Aged; D009362:Neoplasm Metastasis; D010051:Ovarian Neoplasms / Q000188:drug therapy* / Q000473:pathology; D017239:Paclitaxel / Q000008:administration & dosage* / Q000031:analogs & derivatives*; D043823:Taxoids; D016896:Treatment Outcome
chemical_list: D043823:Taxoids; D000077143:Docetaxel; D017239:Paclitaxel; D002945:Cisplatin